Below is a list of the top companies exploring cell therapy treatments for diabetes. [Read more…]
Altucell Releases Evidence in Support of Microencapsulated Sertoli Cells for Reversal of Diabetes
Diabetes is a chronic disease that both reduces life expectancy and reduces quality of life among the afflicted.
According to the Center for Disease Control (CDC), 29.1 million people or 9.3% of the U.S. population has diabetes, including an estimated 8.1 million who are undiagnosed. According to the American Diabetes Association, the “2012 cost of this disease in the U.S. was $245 billion per annum or approximately $500,000 every minute.”
Additionally, nearly 90% of those patients are afflicted by type 2 or “insulin resistant” diabetes. Specifically, the World Health Organization (WHO) estimates that 90% of people around the world who are afflicted by diabetes suffer from type 2 diabetes.
Therefore, progress with a cell therapy based approach for the treatment diabetes would represent a global medical breakthrough. [Read more…]
Reversing Type I Diabetes with Encapsulated Cell Therapy Technology
This is an interview with Gary Harlem, CEO of Altucell, a company exploring novel cell therapy approaches to treating Type I diabetes. In addition to diabetes, the company’s core encapsulation technology is applicable to a wide range of autoimmune and chronic degenerative disorders.
While Altucell is an American company, it has secured intellectual property rights on encapsulation patents from a team of researchers at the University of Perugia, Italy, led by Dr. Riccardo Calafiore, M.D. [Read more…]